Back to SNDX
Post Resch Tallon Group Inc. → SNDX
Post Resch Tallon Group Inc. SNDX Position History
Syndax Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$231K
Q3 2026
Peak value
$479K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $397K |
| Q4 2025 | $479K |
| Q1 2026 | $302K |
| Q2 2026 | $273K |
| Q3 2026 | $231K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $231K | 12.3K | — | — |
| Q2 2026 | $273K | 12.5K | — | — |
| Q1 2026 | $302K | 12.5K | — | — |
| Q4 2025 | $479K | 22.8K | — | — |
| Q3 2025 | $397K | 25.8K | — | — |
Other funds holding SNDX
$123.7M
$123.7M
$118.9M
$116.1M
$114.7M
$114.2M
$114.2M
$111.4M